Cargando…
Peer review in Clinical Pharmacology using the 8-D Assessment
The requirement for editors of clinical pharmacology journals to maintain an overview of the peer review process for manuscripts submitted can be facilitated by use of the 8-D Assessment. The 8-D Assessment comprises peer review criteria to determine if the:1. Design of the study, 2. Diagnoses emplo...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352955/ https://www.ncbi.nlm.nih.gov/pubmed/28218890 http://dx.doi.org/10.5414/CP202971 |
_version_ | 1782515063864688640 |
---|---|
author | Woodcock, Barry G. |
author_facet | Woodcock, Barry G. |
author_sort | Woodcock, Barry G. |
collection | PubMed |
description | The requirement for editors of clinical pharmacology journals to maintain an overview of the peer review process for manuscripts submitted can be facilitated by use of the 8-D Assessment. The 8-D Assessment comprises peer review criteria to determine if the:1. Design of the study, 2. Diagnoses employed, 3. Drug molecules involved, 4. Dosages applied, 5. Data collected, 6. Discussion of the findings, 7. Deductions made, and 8. Documentation are in accord with the objectives of the study and meet the requirements of evidence-based medicine. This tool, although easy to apply, requires a high level of clinical pharmacology expertise, especially in the fields of drug disposition, pharmacokinetics, and drug action. |
format | Online Article Text |
id | pubmed-5352955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dustri-Verlag Dr. Karl Feistle |
record_format | MEDLINE/PubMed |
spelling | pubmed-53529552017-03-21 Peer review in Clinical Pharmacology using the 8-D Assessment Woodcock, Barry G. Int J Clin Pharmacol Ther Viewpoint The requirement for editors of clinical pharmacology journals to maintain an overview of the peer review process for manuscripts submitted can be facilitated by use of the 8-D Assessment. The 8-D Assessment comprises peer review criteria to determine if the:1. Design of the study, 2. Diagnoses employed, 3. Drug molecules involved, 4. Dosages applied, 5. Data collected, 6. Discussion of the findings, 7. Deductions made, and 8. Documentation are in accord with the objectives of the study and meet the requirements of evidence-based medicine. This tool, although easy to apply, requires a high level of clinical pharmacology expertise, especially in the fields of drug disposition, pharmacokinetics, and drug action. Dustri-Verlag Dr. Karl Feistle 2017-03 2017-02-14 /pmc/articles/PMC5352955/ /pubmed/28218890 http://dx.doi.org/10.5414/CP202971 Text en © Dustri-Verlag Dr. K. Feistle http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Viewpoint Woodcock, Barry G. Peer review in Clinical Pharmacology using the 8-D Assessment |
title | Peer review in Clinical Pharmacology using the 8-D Assessment |
title_full | Peer review in Clinical Pharmacology using the 8-D Assessment |
title_fullStr | Peer review in Clinical Pharmacology using the 8-D Assessment |
title_full_unstemmed | Peer review in Clinical Pharmacology using the 8-D Assessment |
title_short | Peer review in Clinical Pharmacology using the 8-D Assessment |
title_sort | peer review in clinical pharmacology using the 8-d assessment |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352955/ https://www.ncbi.nlm.nih.gov/pubmed/28218890 http://dx.doi.org/10.5414/CP202971 |
work_keys_str_mv | AT woodcockbarryg peerreviewinclinicalpharmacologyusingthe8dassessment |